Taillan B, Chichmanian R M, Fuzibet J G, Vinti H, Taillan F, Dellamonica P, Dujardin P
Service de médecine interne I, hôpital de Cimiez, Nice.
Rev Med Interne. 1989 Sep-Oct;10(5):409-11. doi: 10.1016/s0248-8663(89)80045-1.
Three cases are reported of cholestatic hepatitis occurring during treatment with rifampicin for staphylococcal septicemia (2) and tuberculosis (1). There was no previous history of hepatic affection. The administration of rifampicin caused cholestasis alone. No immunoallergic phenomenon has been shown.
报告了3例在使用利福平治疗葡萄球菌败血症(2例)和结核病(1例)期间发生胆汁淤积性肝炎的病例。既往无肝脏疾病史。利福平的使用仅导致胆汁淤积。未出现免疫过敏现象。